| Primary |
| Product Used For Unknown Indication |
26.5% |
| Diarrhoea |
24.6% |
| Drug Use For Unknown Indication |
22.7% |
| Epilepsy |
2.6% |
| Gastroenteritis |
2.6% |
| Nausea |
2.4% |
| Hypertension |
1.9% |
| Abdominal Pain |
1.7% |
| Pain |
1.7% |
| Vomiting |
1.7% |
| Cholangitis |
1.4% |
| Suicide Attempt |
1.4% |
| Accidental Exposure To Product |
1.2% |
| Colorectal Cancer |
1.2% |
| Functional Gastrointestinal Disorder |
1.2% |
| Heart Rate Irregular |
1.2% |
| Non-small Cell Lung Cancer |
1.2% |
| Chemotherapy |
0.9% |
| Colorectal Cancer Metastatic |
0.9% |
| Conjunctivitis |
0.9% |
|
| Toxic Epidermal Necrolysis |
12.5% |
| Intentional Drug Misuse |
9.1% |
| Intestinal Obstruction |
8.0% |
| Ventricular Tachycardia |
8.0% |
| Somnolence |
6.8% |
| Drug Interaction |
5.7% |
| Haematuria |
4.5% |
| Overdose |
4.5% |
| Paraesthesia |
4.5% |
| Completed Suicide |
3.4% |
| Drug Abuse |
3.4% |
| Drug Ineffective |
3.4% |
| Gastrointestinal Obstruction |
3.4% |
| Ileus |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Megacolon |
3.4% |
| Renal Failure Acute |
3.4% |
| Urinary Retention |
3.4% |
| Vomiting |
3.4% |
| Appendicitis Perforated |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
46.9% |
| Diarrhoea |
7.6% |
| Drug Use For Unknown Indication |
6.2% |
| Prophylaxis |
3.8% |
| Gastrinoma |
3.2% |
| Cholecystectomy |
3.2% |
| Cholelithiasis |
3.2% |
| Pain |
3.1% |
| Influenza |
2.5% |
| Ischaemic Heart Disease Prophylaxis |
2.4% |
| Foetal Exposure During Pregnancy |
2.1% |
| Functional Gastrointestinal Disorder |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
2.0% |
| Dyslipidaemia |
1.8% |
| Convulsion |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Duodenal Ulcer |
1.7% |
| Dysmenorrhoea |
1.7% |
| Neuralgia |
1.7% |
| Rheumatoid Arthritis |
1.7% |
|
| Colitis Microscopic |
20.4% |
| Completed Suicide |
11.6% |
| Stevens-johnson Syndrome |
7.5% |
| Vomiting |
7.5% |
| Somnolence |
6.8% |
| Intentional Drug Misuse |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Thrombocytopenia |
4.8% |
| Death |
4.1% |
| Diarrhoea |
4.1% |
| Rash |
4.1% |
| Appendicitis Perforated |
2.7% |
| Intestinal Obstruction |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
| Respiratory Arrest |
2.0% |
| Suicidal Ideation |
2.0% |
| Ventricular Septal Defect |
2.0% |
| Anal Injury |
1.4% |
| Aspiration |
1.4% |
| Cerebrovascular Accident |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.0% |
| Drug Use For Unknown Indication |
12.7% |
| Diarrhoea |
6.6% |
| Crohn's Disease |
5.4% |
| Pain |
5.1% |
| Hypertension |
4.5% |
| Nausea |
4.4% |
| Prophylaxis |
4.2% |
| Breast Cancer |
2.5% |
| Colorectal Cancer Metastatic |
2.3% |
| Depression |
2.1% |
| Colorectal Cancer |
1.9% |
| Hiv Infection |
1.6% |
| Insomnia |
1.5% |
| Hepatic Neoplasm Malignant |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Diabetes Mellitus |
1.4% |
| Multiple Myeloma |
1.4% |
| Rectal Cancer |
1.2% |
|
| Vomiting |
20.3% |
| Weight Decreased |
10.1% |
| Diarrhoea |
6.0% |
| Pyrexia |
5.9% |
| Renal Failure Acute |
5.5% |
| Sepsis |
5.3% |
| Pneumonia |
4.6% |
| Death |
4.4% |
| Pulmonary Embolism |
4.3% |
| Thrombocytopenia |
4.1% |
| Renal Failure |
4.0% |
| White Blood Cell Count Decreased |
3.8% |
| Urinary Tract Infection |
3.1% |
| Nephrotic Syndrome |
3.0% |
| Neutropenic Sepsis |
2.9% |
| Weight Increased |
2.8% |
| Neutropenia |
2.5% |
| Thrombosis |
2.5% |
| Dehydration |
2.4% |
| Nausea |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
86.5% |
| Pain |
8.1% |
| Diabetes Mellitus |
2.7% |
| Epilepsy |
2.7% |
|
| Rash |
60.0% |
| Swelling |
20.0% |
| Paraesthesia |
10.0% |
| Spinal Column Injury |
10.0% |
|
